InsiderTrades

Form 4 for ALKS Alkermes plc.

Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-22 · accession 0001127602-25-006718 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-02-25 2025-02-22+ ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off M - OptEx — +20.0K 77.3K +35% —
DM 2025-02-25 2025-02-22+ ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off F - Tax $35.32 -8,866 69.6K -11% -$313.1K
DM 2025-02-25 2025-02-22+ ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off M - OptEx — -20.0K 15.4K -56% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2025-02-22 M A 12,279 — 75,100 D — — (F1) Each restricted stock unit represents a contingent right to receive one ordinary share.
2 Common Ordinary Shares 2025-02-23 F D 3,414 $35.32 73,923 D — —
3 Common Ordinary Shares 2025-02-23 M A 7,689 — 77,337 D — — (F1) Each restricted stock unit represents a contingent right to receive one ordinary share.
4 Common Ordinary Shares 2025-02-22 F D 5,452 $35.32 69,648 D — —
5 Derivative Restricted Stock Unit Award 2025-02-22 M D 12,279 — 0 D — · — to — 12,279 Ordinary Shares (F1) Each restricted stock unit represents a contingent right to receive one ordinary share. (F2) This award is fully vested in accordance with its terms.
6 Derivative Restricted Stock Unit Award 2025-02-23 M D 7,689 — 15,379 D — · — to — 7,689 Ordinary Shares (F1) Each restricted stock unit represents a contingent right to receive one ordinary share. (F3) Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024.